封面
市場調查報告書
商品編碼
1692247

角膜植入物市場 - 全球產業規模、佔有率、趨勢、機會和預測,按應用、按手術類型、按地區和競爭細分,2020-2030 年預測

Corneal Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Type by Surgery, By Region, and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球角膜植入物市場價值為 5.1268 億美元,預計到 2030 年將達到 7.4215 億美元,預測期內複合年成長率為 6.36%。角膜植入,也稱為角膜移植或角膜移植,是一種用來自捐贈者的健康角膜替換受損或患病角膜的外科手術。角膜是眼睛前部的透明圓頂狀表面,覆蓋虹膜和瞳孔,在將光線聚焦到視網膜上方面起著關鍵作用,這對於清晰的視覺至關重要。進行角膜植入是為了恢復視力並治療影響角膜清晰度和功能的各種角膜疾病或病症。當角膜受損、形狀不規則或生病,導致視力受損或不適時,通常會建議進行角膜植入。對大多數角膜植入物來說,捐贈的角膜來自於逝世時慷慨捐贈角膜的個人。這些捐贈的角膜經過精心篩選、處理並儲存在眼庫中,以確保安全性和適合移植。手術過程包括移除受損或生病的角膜並用捐贈的角膜替換。通常使用縫合線來將移植物固定到位。在一些微創手術中,可以做一個較小的切口,然後透過這個較小的開口將新的角膜組織折疊並插入眼睛中。手術後,患者通常會經歷一段時間的復原。可以遮蓋眼睛並開藥以防止感染和減輕發炎。視力恢復可能需要幾週到幾個月的時間,在此期間患者需要密切監測。全球人口老化更容易患上角膜疾病,包括與年齡相關的疾病。這種人口趨勢推動了對角膜植入物的需求。角膜植入技術的不斷進步,例如人工角膜、合成材料和微創手術技術的開發,提高了角膜移植手術的有效性和安全性。增強患者和醫療專業人員對角膜植入物作為視力矯正和角膜疾病的有效治療選擇的認知。根據個別患者的具體需求客製化角膜植入物的能力正在日益成長。客製化、個人化的治療越來越受歡迎。

市場概況
預測期 2026-2030
2024 年市場規模 5.1268億美元
2030 年市場規模 7.4215億美元
2025-2030 年複合年成長率 6.36%
成長最快的領域 人類角膜
最大的市場 北美洲

主要市場促進因素

技術進步

主要市場挑戰

排斥和併發症

主要市場趨勢

微創手術

目錄

第 1 章:產品概述

第 2 章:研究方法

第 3 章:執行摘要

第 4 章:顧客之聲

第5章:全球角膜植入物市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依應用(圓錐角膜、福克斯營養不良症、傳染性角膜炎、角膜潰瘍等)
    • 按類型(人類角膜、合成角膜)
    • 透過手術(穿透性角膜移植、內皮角膜移植)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第6章:亞太地區角膜植入物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 印度
    • 澳洲
    • 日本
    • 韓國

第7章:歐洲角膜植入物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 8 章:北美角膜植入物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 墨西哥
    • 加拿大

第9章:南美角膜植入物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲角膜植入物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 13 章:全球角膜植入物市場:SWOT 分析

第 14 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章: 大環境分析

第 16 章:競爭格局

  • Florida Lions Eye Bank
  • Alcon Inc.
  • Auro Laboratories Ltd.
  • CorneaGen Inc.
  • AJL Ophthalmic SA
  • DIOPTEX
  • Massachusetts Eye and Ear Associates Inc.
  • San Diego Eye Bank
  • KeraMed, Inc.
  • Presbia PLC

第 17 章:策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 20723

Global Corneal Implants Market was valued at USD 512.68 million in 2024 and and is expected to reach USD 742.15 million by 2030 with a CAGR of 6.36% during the forecast period. Corneal implants, also known as corneal transplantation or corneal grafting, are surgical procedures that involve replacing a damaged or diseased cornea with a healthy cornea from a donor. The cornea is the clear, dome-shaped front surface of the eye that covers the iris and the pupil, and it plays a critical role in focusing light onto the retina, which is essential for clear vision. Corneal implants are performed to restore vision and treat various corneal diseases or conditions that impact the clarity and function of the cornea. Corneal implants are typically recommended when the cornea is damaged, irregularly shaped, or diseased, resulting in vision impairment or discomfort. For most corneal implants, the donor cornea comes from individuals who have generously donated their corneas upon their passing. These donor corneas are meticulously screened, processed, and stored in eye banks to ensure safety and suitability for transplantation. The surgical process involves removing the damaged or diseased cornea and replacing it with the donor cornea. Sutures are often used to secure the graft in place. In some minimally invasive procedures, a smaller incision may be made, and the new corneal tissue is folded and inserted into the eye through this smaller opening. After the surgery, patients typically experience a period of healing and recovery. The eye may be patched, and medications are prescribed to prevent infection and reduce inflammation. Vision recovery can take several weeks to months, and patients are closely monitored during this time. The aging global population is more susceptible to corneal diseases, including age-related conditions. This demographic trend drives the demand for corneal implants. Ongoing advancements in corneal implant technologies, such as the development of artificial corneas, synthetic materials, and minimally invasive surgical techniques, have improved the effectiveness and safety of corneal transplantation procedures. Enhanced patient and healthcare professional awareness regarding the availability of corneal implants as an effective treatment option for vision correction and corneal diseases. The ability to tailor corneal implants to the specific needs of individual patients is a growing trend. Customized and personalized treatments are gaining popularity.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 512.68 Million
Market Size 2030USD 742.15 Million
CAGR 2025-20306.36%
Fastest Growing SegmentHuman Cornea
Largest MarketNorth America

Key Market Drivers

Technological Advancements

Researchers have been developing artificial corneas made of biocompatible materials, such as synthetic polymers. These artificial corneas offer an alternative to traditional donor corneal transplants, addressing the issue of donor scarcity and rejection. The use of 3D printing technology has enabled the creation of customized corneal implants. Surgeons can design and fabricate corneal implants that precisely match the patient's eye, leading to improved visual outcomes and reduced risk of complications. Descemet's membrane endothelial keratoplasty (DMEK) and Descemet's stripping automated endothelial keratoplasty (DSAEK) are minimally invasive procedures that replace only the damaged inner layer of the cornea. These techniques offer faster recovery times and reduced complications compared to traditional full-thickness corneal transplants. Femtosecond lasers are used to create precise incisions during corneal transplant surgeries. This technology allows for greater accuracy and safety in the surgical process. Corneal inlays, often used in procedures like Keraring, are small, implantable devices that can correct vision problems such as keratoconus or irregular astigmatism. These inlays are designed to improve the cornea's shape and, consequently, vision. The development of advanced biomimetic hydrogels for use as background materials in corneal implants has improved their compatibility with the eye and reduced the risk of post-operative complications.

Key Market Challenges

Rejection and Complications

The human body's immune system is designed to protect against foreign invaders, including transplanted tissue. In the case of corneal transplantation, the recipient's immune system can recognize the donor cornea as foreign and may initiate an immune response to reject it. This immune response can lead to graft rejection, which may result in vision loss. Graft failure can occur when the transplanted cornea does not integrate properly with the recipient's eye or when complications arise, leading to poor visual outcomes. Graft failure can be caused by various factors, including infection, poor wound healing, or issues related to donor tissue. Post-surgical infections can pose a significant risk to corneal implant recipients.

Infections can compromise the success of the transplant and may lead to severe complications, including graft failure. Irregular healing and wound-related issues after corneal implant surgery can induce astigmatism, which can distort vision. This is a common complication that patients may face. Elevated intraocular pressure (IOP) resulting from corneal implant surgery or associated treatments can lead to glaucoma, a condition that can cause optic nerve damage and vision loss if not managed appropriately. In procedures like DMEK or DSAEK, there may be a risk of endothelial cell loss, which can lead to graft failure or persistent corneal edema. The use of corticosteroid medications to prevent graft rejection can lead to side effects, including cataracts and increased intraocular pressure. In conditions like keratoconus, where the cornea progressively thins and bulges, corneal hydrops may occur post-implantation, causing sudden corneal swelling and scarring.

Key Market Trends

Minimally Invasive Procedures

Minimally invasive techniques often result in quicker post-operative recovery. Patients experience less discomfort and a shorter healing period, allowing them to return to their normal activities sooner. Minimally invasive procedures can lead to fewer complications compared to traditional, full-thickness corneal transplant procedures. This is particularly important in reducing the risk of graft rejection and infection. Minimally invasive techniques involve smaller incisions, which can lead to less trauma to the eye. Smaller incisions can also lead to better wound healing and less astigmatism. These procedures often result in improved visual outcomes, as they target the specific layers of the cornea that are affected by certain conditions, such as endothelial diseases like Fuchs' dystrophy. Minimally invasive procedures can be highly customized to the patient's individual needs. Surgeons can precisely target the affected area of the cornea, leading to better outcomes. Minimally invasive techniques tend to reduce astigmatism, which can significantly improve the patient's visual quality. Some minimally invasive procedures, such as Descemet's membrane endothelial keratoplasty (DMEK) and Descemet's stripping automated endothelial keratoplasty (DSAEK), focus on replacing only the inner layers of the cornea, which can be especially beneficial for certain conditions like Fuchs' dystrophy. Patients often experience a faster return to good vision with minimally invasive procedures, which is especially important for their quality of life and daily activities.

Key Market Players

  • Florida Lions Eye Bank
  • Alcon Inc.
  • Auro Laboratories Ltd.
  • CorneaGen Inc.
  • AJL Ophthalmic S.A.
  • DIOPTEX
  • Massachusetts Eye and Ear Associates Inc.
  • San Diego Eye Bank
  • KeraMed, Inc.
  • Presbia PLC

Report Scope:

In this report, the Global Corneal Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Corneal Implants Market, By Type:

  • Human Cornea
  • Synthetic

Corneal Implants Market, By Application:

  • Keratoconus
  • Fuchs Dystrophy
  • Infectious Keratitis
  • Corneal Ulcers
  • others

Corneal Implants Market, By Surgery:

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty

Corneal Implants Market, By region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Australia
    • Japan
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Corneal Implants Market.

Available Customizations:

Global Corneal Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Corneal Implants Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, others)
    • 5.2.2. By Type (Human Cornea, Synthetic)
    • 5.2.3. By Surgery (Penetrating Keratoplasty, Endothelial Keratoplasty)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. Asia Pacific Corneal Implants Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Type
    • 6.2.3. By Surgery
    • 6.2.4. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Corneal Implants Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Surgery
    • 6.3.2. India Corneal Implants Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Surgery
    • 6.3.3. Australia Corneal Implants Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Surgery
    • 6.3.4. Japan Corneal Implants Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Application
        • 6.3.4.2.2. By Type
        • 6.3.4.2.3. By Surgery
    • 6.3.5. South Korea Corneal Implants Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Application
        • 6.3.5.2.2. By Type
        • 6.3.5.2.3. By Surgery

7. Europe Corneal Implants Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Type
    • 7.2.3. By Surgery
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Corneal implants Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Surgery
    • 7.3.2. Germany Corneal Implants Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Surgery
    • 7.3.3. Spain Corneal Implants Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Surgery
    • 7.3.4. Italy Corneal Implants Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Surgery
    • 7.3.5. United Kingdom Corneal Implants Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Surgery

8. North America Corneal Implants Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Type
    • 8.2.3. By Surgery
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Corneal Implants Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Surgery
    • 8.3.2. Mexico Corneal Implants Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Surgery
    • 8.3.3. Canada Corneal Implants Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Surgery

9. South America Corneal Implants Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Type
    • 9.2.3. By Surgery
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Corneal Implants Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Surgery
    • 9.3.2. Argentina Corneal Implants Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Surgery
    • 9.3.3. Colombia Corneal Implants Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Surgery

10. Middle East and Africa Corneal Implants Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Type
    • 10.2.3. By Surgery
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Corneal Implants Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Surgery
    • 10.3.2. Saudi Arabia Corneal Implants Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Surgery
    • 10.3.3. UAE Corneal Implants Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Surgery

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Corneal implants Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

  • 16.1. Florida Lions Eye Bank
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (In case of listed companies)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Alcon Inc.
  • 16.3. Auro Laboratories Ltd.
  • 16.4. CorneaGen Inc.
  • 16.5. AJL Ophthalmic S.A.
  • 16.6. DIOPTEX
  • 16.7. Massachusetts Eye and Ear Associates Inc.
  • 16.8. San Diego Eye Bank
  • 16.9. KeraMed, Inc.
  • 16.10. Presbia PLC

17. Strategic Recommendations

18. About Us & Disclaimer